Sorrento Therapeutics (SRNE)
(Delayed Data from OTC)
$0.01 USD
0.00 (-18.03%)
Updated Jun 7, 2024 03:33 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Sorrento Therapeutics, Inc. [SRNE]
Reports for Purchase
Showing records 161 - 180 ( 186 total )
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
2016 Healthcare Sector Outlook: Year Ahead Perspectives
Provider: H.C. Wainwright & Co., Inc.
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Assuming Coverage with Buy and $45 Price Target
Provider: Rodman & Renshaw, Co.
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Assuming Coverage with Buy and $45 Price Target
Provider: H.C. Wainwright & Co., Inc.
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
JV to Develop Targeted Cancer Therapies; Reiterate Buy
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: RAMAKANTH S
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
On the Road to Curing Cancer: Recent Developments and Future Outlook
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: RAMAKANTH S
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Combining Immunotherapy Platforms to Maximize Potential
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: RAMAKANTH S
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
NantWorks Agreement Underscores Cynviloq Potential; Reiterate Buy
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: RAMAKANTH S
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Cynviloq Stepping Up to the Plate; 1Q15 Update; Reiterate Buy
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: RAMAKANTH S
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Positive TRIBECA Top-Line Data Clears Path for Cynviloq Registration; Reiterate Buy
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: RAMAKANTH S
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Cynviloq Profile Appears Better Than the Competition; Reiterate Buy
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: RAMAKANTH S
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
NantWorks Relationship Growing Stronger; New $20 Price Target; Reiterate Buy
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: RAMAKANTH S
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
2015 Preview: Industry Signals Imply Continued Growth
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: RAMAKANTH S
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Gearing Up to Launch a Conquest; Reiterate Buy
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: RAMAKANTH S
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
JV with NantWorks; Huge Validation for G-MAB Platform; Reit Buy
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: RAMAKANTH S
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G